ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,279Medicare Part D Prescriptions Filled, Including Refills

Rank: 128 out of 1111

$794K Total Retail Price of All Prescriptions

Rank: 78 out of 1111

385 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 385 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 385 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 9,065 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$70 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
CITALOPRAM HBR 384 317 1 14
OMEPRAZOLE 337 268 2 4
LISINOPRIL 336 275 3 2
LEVOTHYROXINE SODIUM 335 314 4 3
HYDROCODONE-ACETAMINOPHEN 315 261 S3 5 1
DONEPEZIL HCL 291 264 6 25
FUROSEMIDE 289 252 7 6
POLYETHYLENE GLYCOL 3350 284 175 8 45
AMLODIPINE BESYLATE 237 212 9 7
NAMENDA 234 209 10 31
SIMVASTATIN 215 141 11 5
METOPROLOL TARTRATE 214 153 12 12
GABAPENTIN 212 173 13 10
MIRTAZAPINE 205 161 14 52
WARFARIN SODIUM 155 120 15 19
KLOR-CON M20 151 112 16 79
POTASSIUM CHLORIDE 148 139 17 9
METFORMIN HCL 142 100 18 8
SERTRALINE HCL 138 137 19 24
CARVEDILOL 131 112 20 21
PHENYTOIN SODIUM EXTENDED 127 105 21 126
LANTUS 123 101 22 46
FAMOTIDINE 119 101 23 77
LYRICA 118 81 24 62
NOVOLOG 115 89 25 104
TRAZODONE HCL 109 102 26 32
HYDROXYZINE HCL 104 82 R 27 159
LEVETIRACETAM 98 48 28 111
BACLOFEN 97 22 29 119
ATORVASTATIN CALCIUM 92 72 30 15
CYMBALTA 91 53 31 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 91 82 31 71
CLOPIDOGREL 89 76 33 30
DIVALPROEX SODIUM 85 55 34 82
RISPERIDONE 84 58 35 60
ENOXAPARIN SODIUM 83 27 36 228
RANITIDINE HCL 82 69 37 29
HYDROCHLOROTHIAZIDE 81 51 38 11
PANTOPRAZOLE SODIUM 79 66 39 50
FENTANYL 75 64 S2 40 65
QUETIAPINE FUMARATE 71 63 41 76
ADVAIR DISKUS 71 36 41 43
ABILIFY 68 45 43 123
ESCITALOPRAM OXALATE 68 68 43 78
JANTOVEN 67 67 45 156
TRAMADOL HCL 64 59 46 13
NAPROXEN 59 49 47 85
ALENDRONATE SODIUM 58 58 48 35
LEVOFLOXACIN 56 53 49 88
IBUPROFEN 55 47 50 66
NITROFURANTOIN MONO-MACRO 54 50 51 149
PRAVASTATIN SODIUM 53 50 52 17
DIGOXIN 52 52 53 47
ZOLPIDEM TARTRATE 51 35 54 16
LOPERAMIDE 51 43 54 165
ALBUTEROL SULFATE 50 41 56 136
PROMETHAZINE HCL 50 39 R 56 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.